Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma

Table 2 Multivariate regression model of predictors for longterm survival of three years and more after start of therapy

Predictors	Cut-off	P-value	Odd's ratios	Confidenceinterval
AFP	< 400 ng/mL	NS
Fever	< 38°C	NS
CHE-level at follow up	Change < 1 mU/mL	0.05	6	2.4-10.1
No of tumor lesions	≤ 5	0.01	11.1	3.3-22.3
Child-Pugh	Child A	NS
Ascites	No ascites	0.03	12.2	4.7-30.3
Portal vein thrombosis	No thrombosis	NS
Okuda	Okuda stage 1	NS
Severe complications	No complication	NS
Maximum tumor size	≤ 5 cm	0.04	6.1	1.3-17.5
Type of treatment	TACE-PEI comb (I) vs other groups	0.05	4.3	1.2-14.7

P-values, Odd's ratios and confidence intervalls are shown for all significant variables. R² = 43%.